Get started
Mural Oncology plcMural Oncology plcMural Oncology plc

Mural Oncology plc

No trades
See on Supercharts
Overview
Financials
News Ideas Minds Technicals Forecast

MURA fundamentals

Key facts

Market capitalization—
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)—
Founded—
Employees (FY)—
CEO—
Website—
About

Mural Oncology Plc is a clinical-stage oncology company. It engages in the business of discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. The company was founded on May 31, 2017 and is headquartered in Dublin, Ireland.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

MURA does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company